Key facts
- This page summarizes Mark Graves's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 May 2022, 16:44.
Mark Graves - 09 May 2022 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)
- Reporting relationship
- SVP & Chief Compliance Officer
- Issuer ticker
- MDXG
- Reported as of
- 09 May 2022
- Net transaction value
- -$13,622
- SEC form
- 4
- Accepted by SEC
- 10 May 2022, 16:44:46 UTC
- Prior SEC filing
- 12 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- William F. Hulse, as attorney-in-fact for Mark Graves
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Graves filed Form 4 for MIMEDX GROUP, INC. (MDXG) on 10 May 2022.
Change
- Previous filing in this sequence was filed on 12 Apr 2022.
- Current net transaction value: -$13,622.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDXG
transaction
Common Stock
Sale
- Transaction value
- $13,622
- Shares
- -3,891
- Change %
- -2.8%
- Price
- $3.50
- Shares after
- 133,608
- Date
- 09 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
Footnote F2
The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $3.50 to $3.51, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.